[1. Driscoll, P., and K. Blittig: Rev, Env. Health 1 (1973) 113-133.]Search in Google Scholar
[2. Frankenhaeuser, M., A. Myrsten, M. Waszah, A. Neri, and B. Post: Psychopharmacologica 13 (1968) 311-319. 10.1007/BF004143425722167]Search in Google Scholar
[3. Ashton, H., J. E. Millrnan, R. Telford, and J. W. Thornpson: Brit. ]. Pharm. 48 (1973) 715-717.10.1111/j.1476-5381.1973.tb08260.x17761434788213]Search in Google Scholar
[4. Frankenhaeuser, M., A. L. Myrsten, B. Post, and G. Johansson: Psydtopharmacologica 22 (1971) 1--'1. 10.1007/BF004014615119573]Search in Google Scholar
[5. Hall, G. H., and C. F. Morrison: Nature 243 (1973) 199-201.10.1038/243199a04735896]Search in Google Scholar
[6. Dunn, W. L., Jr.: Smoking behaviour I Motives and incentives; V. H. Winston and Sons, Washington, D. C., 1973. ]Search in Google Scholar
[7. Stauffer, H. P.: Prii.ventivmed. 19 (1974) 55-62.]Search in Google Scholar
[8. Coresfa Standard Method No. 10 (1968): Coresta Information Bulletin 1969-1, 24-33; Coresta Head Office, 53 Quai d'Orsay, Paris-7. ]Search in Google Scholar
[9. Jocelyn, P. C.: Biochemistry of the SH-group; Academic Press, New York and London, 1972. ]Search in Google Scholar
[10. Testa, A., C. Joigny: Dosage par chromatographie en phase gazeuse (CPG) de l'acrolei.ne et d'autres composes a,~-insatures de la phase gazeuse de la fumee de cigarette; Paper No. 86, CorestafTCRC Joint Con£., WHliamsburg, V a., USA, 1972.]Search in Google Scholar
[11. Williamson, ]. T., and D. R. Allrnan: Beitr. Tabakforsch. 3 (1966) 590-596.]Search in Google Scholar
[12. Waltz, P., and M. Hliusermann: Beitr. Tabakforsch. 3 (1965) :t6g-202.]Search in Google Scholar
